Boardroom Alpha
Start trial
10-K primary document
SMTI · Annual Report (Form 10-K) · Filed March 24, 2026

Sanara Medtech Inc — 10-K exhibit

ex21-1.htm
Sanara Medtech Inc on Boardroom Alpha

 

EXHIBIT 21.1

 

Subsidiaries of Sanara MedTech Inc.

 

The following is a list of subsidiaries of Sanara MedTech Inc., a Texas corporation (the “Company”), as of December 31, 2025, the states in which they are organized and the Company’s percentage ownership of the issued and outstanding stock or other equity interests for each entity. The names of particular subsidiaries may be omitted if the unnamed subsidiaries, considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary as of the end of the year covered by the annual report on Form 10-K of which this Exhibit 21.1 forms a part. (See the definition of “significant subsidiary” in Rule 1-02(w) (17 CFR 210.1-02(w)) of Regulation S-X.)

 

Name of Subsidiary  State of Incorporation  Direct or Indirect Ownership Percentage 
CarePICS, LLC  Delaware   100%(1)
Cellerate, LLC  Texas   100%
Wound Care Innovations, LLCTT  Nevada   100%
Sanara CMP, LLC  Texas   100%(2)
Rochal Technologies, LLC  Texas   100%
Tissue Health Plus, LLC  Delaware   100%(3)
Precision Healing, LLC  Delaware   100%(4)
Pixalere Healthcare USA, LLC  Delaware   73%(5)
Scendia Biologics, LLC  Delaware   100%
Sanara MedTech Applied Technologies, LLC  Texas   100%
Sanara Collagen Peptides, LLC  Delaware   90%

 

(1)Ownership of CarePICS, LLC is held indirectly through Tissue Health Plus, LLC, a wholly owned subsidiary of the Company.
  
(2)In 2024, Sanara Biologics, LLC was renamed to Sanara CMP, LLC.
  
(3)In 2024, United Wound and Skin Solutions, LLC was renamed to Tissue Health Plus, LLC.
  
(4)Ownership of Precision Healing, LLC is held indirectly through Tissue Health Plus, LLC, a wholly owned subsidiary of the Company.
  
(5)Ownership of Pixalere Healthcare USA, LLC is held indirectly through Tissue Health Plus, LLC, a wholly owned subsidiary of the Company.

 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer